StockWatch
·
RACL GEARTECH LTD · QQ1 FY-2027 · THE CALL

Strong YoY growth masks Q1 flatness; new programs ramping cautiously

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsRACLGEARRACL Geartech Ltd01 Sept 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Met 500 Cr FY26 target; on track for 565±5% FY27 guidance. New programs progressing as outlined, but no upside surprise evident.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong YoY revenue (31.5%) masks sequential stall (+0.5%) and PAT weakness (7.7% vs revenue growth). New catalysts (BMW, Royal Enfield, KTM recovery) are real but ramping cautiously; management deliberately held guidance despite tailwinds, signaling measured confidence. Multi-supplier risk on Royal Enfield and execution risk on adjacent verticals (aerospace, robotics) are material.

₹132.3 Cr

Revenue · +31.5% YoY

₹8.9 Cr

Reported PAT · +7.7% YoY

Flat

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

KTM has bounced back to pre-COVID levels

MET

Management claims recovery but no revenue breakout shown; KTM contribution not quantified in this quarter

Royal Enfield is a very big domestic order

OVERSTATED

10,000 sets/month nominated, currently sustaining 7.5-8,000 units/month; 8 months into ramp, still sub-scale

BMW Project Venus SOP on track for October 2026

MET

Level 1 approval done, final approval scheduled Oct 24, pilot supplies already started

Coming times showing very encouraging outlook

MISS

QoQ revenue +0.5%, PAT -27.9% QoQ; management did NOT upgrade FY27 guidance despite new catalysts

Maintaining EBITDA margin of ~24%

MET

Q1 OPM reported at 24.1%; consistent with prior year 24.1%

Earnings quality

What changed since the last call

Deltas vs. the prior call

KTM revenue stabilizing vs prior concern

Upgrade

Prior call: KTM in recovery mode post-insolvency. Q1 call: 'Bounced back, pre-COVID levels or slightly above, new Duke 790 launching, good forecast.' Narrative upgraded but no hard numbers shared.

Royal Enfield empanelment announced, scaling production

New

January 2026 commercial supplies began; 10,000 sets/month nominated (350 CC motorcycle). Currently sustaining 7.5-8,000. Multi-supplier, confidential scale withheld by management.

BMW Project Venus accelerating approvals

Upgrade

Prior: Project underway, approvals pending. Q1: Level 1 approval granted, final approval Oct 24, pilot supplies started. Incremental de-risking.

FY27 guidance NOT revised upward

Neutral

Despite KTM recovery, Royal Enfield win, BMW acceleration, management explicitly held 565±5% guidance. Rationale: customers not growing >20%, RACL share <20% per customer, mid-year guidance changes inappropriate.

Capex disclosed; heat treatment replacement underway

Neutral

₹77.4 Cr capex: ₹40 Cr heat treatment plant replacement (foundation Jan, commissioning Jan 27), ₹35 Cr capacity expansion. Strategic but capital-intensive; no acceleration vs plan.

The Q&A

Moderate. Analysts pressed on guidance revision (Shashank Kanodia, Abhisar Jain), Royal Enfield scale and market share (Jainam Madrecha), ZF trajectory (Prabh answered directly). Management stood firm: not upgrading mid-year, withheld Royal Enfield volume % citing competitive risk, and emphasized incubation strategy for new verticals. Tone was measured, not defensive; management held their line on cautious execution.

The exchanges that mattered

KTM recovery trajectory — Sid

Answered

KTM Austria bounced back to pre-COVID; RACL's Austrian subsidiary serves KTM. Bajaj India multi-sourcing strategy ongoing; RACL already supplies Royal Enfield, TVS. New opportunities with Bajaj over time.

BMW SOP status — Piyush Jain

Answered

Level 1 approval done, conditional shipments started, final approval Oct 24. Pilot supplies moving to customer cars now. Everything on track, no delays.

Royal Enfield details — Piyush Jain

Partial

350 CC model, 10,000 sets/month nominated, currently 7.5-8,000 sustaining. Other new models under confidentiality. Competitive sensitivity; won't disclose %. Sizable business.

ZF business trajectory — Piyush Jain

Answered

Prior sluggishness due to OEM car models. X5 platform now active, 50-60% utilization. Peak revenue shifted 2028→2030. Electric power steering project ramping end-2027/mid-2028 for American OEM; another big opportunity.

Non-auto diversification — Abhisar Jain

Answered

Aerospace/civil aviation (Airbus focus), actuators/micromotors, robotics (high demand but early stage, few Indian players). Incubation strategy: test, then scale. Will update investors in 1-2 years.

Guidance revision possibility — Shashank Kanodia

Dodged

Guidance given once yearly. Even if customer grows 50-60%, RACL's share <20% per customer. Wouldn't revise mid-year. Will perform within 565±5% benchmark; possible upside but no formal change.

EBITDA margin sustainability — Shashank Kanodia

Partial

Should be happy accepting these margins, maintained long-term. Nothing stationary; 2% variance quarter-to-quarter normal. Aspiration is to maintain baseline profitability.

Tax rate outlook — Shashank Kanodia

Answered

Blended FY27 tax rate: 25.62%. Q1 elevated due to surcharge rate change in deferred tax calculation. This was explained in profitability slide.

Royal Enfield outsourcing pattern — Nisarg Shah

Answered

Yes. OEMs want to focus on assembly (commanding position). Supply chain maturity in India now allows this. RACL single-source for export; domestic OEMs multi-source. Creating niche in premium segment.

Precision manufacturing barriers — Nisarg Shah

Answered

Not making; it's consistency at scale. Process capability, traceability, people/technology to produce 100K+ parts/month reliably. Customers won't take risk; RACL A-rated supplier = support.

Royal Enfield capacity planning — Jainam Madrecha

Answered

Multi-supplier customer; we invest cautiously. First prove demand sustainable long-term, then add capacity. No idle capacity; won't jump on demand spikes. Deliberate ramp-up.

Product lifecycle turnover — Jainam Madrecha

Answered

No major end-of-life products today. One project ending but successor model (higher value-add) replacing it. Every 2-3 years add new customer, existing customers add new models.

BMW sole-source confirmation — Jainam Madrecha

Answered

Yes. Export business model: sole source per component until EOL. Global OEM strategy (supply chain risk in field). Domestic (multi-supplier) is different.

ZF competitive leverage — Bhargav Buddhadev

Answered

Large ZF portal RFQ system (no human intervention). Buyers globally upload requirements; RACL marketing monitors, bids if suitable. Automatic discovery; no lobbying needed.

Risk mitigation on project failures — Bhargav Buddhadev

Answered

Yes, indirectly. Customers support suppliers through cost increases, alternative business, or cash if model fails. Depends on relationship strength (A-rated vs C-rated). RACL is A-rated.

RFQ surge from Europe — Bhargav Buddhadev

Answered

True, witnessing RFQ spike. Many are RFIs (requests for information) not firm RFQs. Geopolitical rebalancing real; supply chains being rewritten. Cautious optimism. Will pursue opportunity.

Capex for next 3 years — Adi

Partial

This year ₹77.4 Cr disclosed. Next year's capex will come in January. Beyond 2028-29, too early. Gear business capital-intensive; regular capex needed for growth.

5-year growth ambition & M&A — Adi

Answered

15-20% annual growth, target to double revenue in 3-4 years. Non-auto opportunities (aerospace, actuators, robotics, defense) identified. Incubation model; no aggressive M&A planned yet.

Guidance

Forward guidance and management's confidence

FY27 revenue ~570 Cr (±5%, = 541.5-598.5 Cr)

High

Guidance reaffirmed, not revised upward. Management explained: customers not growing >20%, RACL <20% per customer, mid-year revisions not appropriate. Q1 run-rate suggests 529 Cr annualized (below mid-point); FY27 will need Q2-Q4 acceleration.

EBITDA margin ~24.1%, maintained

High

Q1 delivered 24.1%; management aspires to maintain. Acknowledged 2% variance normal quarter-to-quarter. No margin expansion target.

FY27 capex ₹77.4 Cr (₹40 Cr heat treatment replacement + ₹35 Cr capacity)

High

Foundation laid Jan 26, building completion Oct 26, equipment arrival Sept-Oct, commissioning Oct-Dec, trial production Jan 27. Replacement is non-discretionary; expansion tied to customer ramps.

Risks the call surfaced

Ranked by how much they should concern a holder

Customer concentration

Medium

29 active customers is diversified, but loss of major customer (BMW, Royal Enfield, KTM, ZF) would be material. Royal Enfield multi-supplier adds risk.

Royal Enfield execution

Medium

10,000 units/month nominated; currently 7.5-8,000. Multi-supplier model means RACL could lose share if costs rise or alternative suppliers qualify. Domestic market highly price-sensitive per management.

Sequential revenue weakness

Medium

QoQ revenue +0.5% despite 31.5% YoY growth signals Q1 weakness or customer order lumps. PAT -27.9% QoQ is sharp; tax impact (surcharge rate change) cited but underlying margin may be under pressure.

Capex execution and debt

Medium

₹77.4 Cr capex in FY27 (14% of annual revenue) is significant. Heat treatment plant on schedule but equipment delivery Sept-Oct critical path; delays post-commissioning (Jan 27) would impact expansion timeline and ROI.

Long-term adjacency execution

Low

Management mentioned aerospace (Airbus), robotics, actuators, industrial components as 2-3 year opportunities, but no revenue materialization and execution unknown. Distracts capex and management attention without current business impact.

Management

Score 7/10. Clear and structured. Transparent on challenges (energy crisis, geopolitical risks), catalysts (BMW, Royal Enfield, KTM recovery), and constraints (no mid-year guidance revision). Withheld some competitive details (Royal Enfield volume %, pricing) citing risk; reasonable but limits transparency. Strong track record. Met 500 Cr FY26 target, on track for 565±5% FY27. Heat treatment plant capex execution on timeline (foundation Jan, commissioning Jan 27 on track). New customer wins (BMW, Royal Enfield) progressing but still ramping; not yet transformative.

What to watch next
  • 1 · Oct 24, 2026

    BMW Project Venus final approval sign-off; pilot supplies ongoing

  • 2 · Dec 2026

    Heat treatment plant commissioning (foundation laid Jan 26); switch from LPG to electric

  • 3 · Jan 2027

    Heat treatment plant trial production; capex cycle easing post-commissioning

Multi-supplier risk on Royal Enfield and execution risk on adjacent verticals (aerospace, robotics) are material.

Informational and educational content only. Not investment advice.